NCT04099121View on ClinicalTrials.gov

Evaluation of 3D Translabial Ultrasound Imaging for Pessary Size Estimation

NACompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

September 5, 2023

Study Completion Date

November 1, 2023

Conditions

Prolapse

Interventions

DEVICE

Ultrasound Imaging

3D ultrasound of the pelvic floor and vaginal cavity will be obtained by using a commercial ultrasound system.

Trial Locations (1)

N6A 5W9

Victoria Hospital, London

Sponsors

Collaborators (1)

Cosm Medical Corp.

All Listed Sponsors

collaborator

Cosm Medical Corp.

UNKNOWN

lead

Western University, Canada

OTHER

NCT04099121 - Evaluation of 3D Translabial Ultrasound Imaging for Pessary Size Estimation | Biotech Hunter | Biotech Hunter